Benefits of Satoris Approach in Alzheimer's Diagnosis

Differences that matter for patients and physicians.

• Simplicity. The Satoris test uses blood rather than cerebro-spinal fluid, for minimally invasive sample collection. The test features minimal sample preparation and fewer process steps than nucleic acid or mass spec procedures. The result is same-day turnaround or results.
• Accuracy. The Satoris test demonstrates ~90% accuracy based on samples tested to date. Our antibody-based analysis enables the identification and quantification of individual proteins associated with Alzheimer’s disease.
• Multivariate analysis. As opposed to tests based on only one or two biomarkers, Satoris protein panels are especially useful for heterogenous and dynamic diseases such as Alzheimer’s disease.

Early diagnosis leads to early treatment, which means:

• Earlier stabilization or slowed progression of Alzheimer’s disease symptoms
• Improved quality of life and reduced burden to caregivers
• Delayed entrance into an institutionalized care setting
• Reduced costs of caring for individual patients and collectively, potential savings of billions of dollars to the healthcare system